Karyopharm Therapeutics Inc. Notes Issued
Karyopharm Therapeutics Inc. (KPTI) reported Notes Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:NotesIssued1 · last filed 2026-02-13
- Karyopharm Therapeutics Inc. notes issued for the quarter ending 2025-12-31 was $0.00.
- Karyopharm Therapeutics Inc. notes issued for the quarter ending 2025-09-30 was $0.00.
- Karyopharm Therapeutics Inc. notes issued for the quarter ending 2024-12-31 was $0.00.
- Karyopharm Therapeutics Inc. notes issued for the quarter ending 2024-09-30 was $0.00.
- Karyopharm Therapeutics Inc. notes issued for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Karyopharm Therapeutics Inc. notes issued for fiscal 2024 was $15.00M.
- Karyopharm Therapeutics Inc. notes issued for fiscal 2023 was $0.00.
- Karyopharm Therapeutics Inc. notes issued for fiscal 2022 was $0.00.
| Period end | Notes Issued 3 month | Notes Issued 6 month | Notes Issued 9 month | Notes Issued 12 month | Notes Issued 57 month | Notes Issued 60 month | Notes Issued 63 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $0.00 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $0.00 10-Q · filed 2025-11-03 | |||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-11 | ||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $15.00M 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $15.00M 10-Q · filed 2025-11-03 | |||||
| 2024-06-30 | $15.00M 10-Q · filed 2025-08-11 | ||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $0.00 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $0.00 10-Q · filed 2024-11-05 | |||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-06 | ||||||
| 2022-12-31 | $0.00 10-K · filed 2025-02-19 | ||||||
| 2014-03-31 | $0.00 derived: 10-Q 63 month − 10-K 60 month · filed 2014-05-08 | $700.00K 10-Q · filed 2014-05-08 | |||||
| 2013-12-31 | $700.00K 10-K · filed 2014-03-21 | ||||||
| 2013-09-30 | $700.00K 10-Q/A · filed 2013-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |